Kelly Chibale, Founder and Director of H3D and Neville Isdell Chair, and Nina Lawrence, Senior Investigator, presented at the J.C. Flowers Foundation’s Isdell:Flowers Cross Border Malaria Initiative’s 2020 Round Table on February 27th and 28th in Livingstone, Zambia. The duo, who spoke on a panel discussing scientific highlights in the field of malaria elimination, described the importance of developing new medicines for malaria elimination and eradication with an African-centric design.
UCT’s Drug Discovery and Development Centre (H3D) aims to bring new medicines “from the bench to the bedside”. But how acquainted are prospective healthcare professionals with the difficulties of developing new treatments? Conversely, are research scientists aware of the challenges faced by medical professionals at the frontline of public healthcare in South Africa? These were the questions that the second collaboration between H3D and SHAWCO Health, UCT’s student-run community outreach organisation, sought to address.
Recently, H3D hosted a lunch in honour of Mr Neville Isdell to thank him for his generosity and leadership. Mr Isdell donated approximately R18 million towards the establishment of a five-year Neville Isdell Chair in African-centric Drug Discovery and Development at H3D.
Antimicrobial resistance (AMR) has been an ongoing threat to public health in South Africa as well as other countries in Africa. Disturbingly, the burden in the continent from infectious diseases has also been on the rise. Part of the reason is the persistence of infections associated with tropical regions as well as the higher rates of poverty and greater spread of drug resistance.